---

"I am preparing for [FMG / NEET-PG / USMLE / INICET] exams. From [subject name] (e.g., Physiology), give me the high-yield / hot topics I must read from [book name, e.g., Guyton & Hall / Ganong / Gray's Anatomy] for the chapter/topic: [chapter or topic name, e.g., Renal System / GFR / Countercurrent mechanism].

For each topic, tell me:

1. The specific subtopics or concepts I must know
2. Commonly asked exam points or one-liners
3. Any important diagrams, values, or numbers to remember
4. MCQ traps or commonly confused points"

---

"I am preparing for NEET-PG and INICET. From Physiology, give me the high-yield hot topics I must read from Guyton & Hall for the Renal System chapter.

For each topic, tell me:

1. Specific subtopics and concepts I must know
2. Commonly asked exam points or one-liners
3. Important diagrams, values, or numbers to remember
4. MCQ traps or commonly confused points"

---

• Be specific about the exam - FMG, NEET-PG, and INICET have different weightages. Mention all if you want coverage for all three.
• Mention the book - Say "from Guyton" or "from Ganong" so I pull content from that exact textbook rather than giving generic notes.
• One chapter at a time - Instead of "entire physiology," ask topic by topic (e.g., "Cardiac Output," then "Renal Physiology") for a focused, deep answer.
• Ask for previous year MCQ analysis - Add "also mention which subtopics have appeared in past NEET-PG / INICET papers" to get exam-trend-based prioritization.
• Ask for comparison tables - Add "give comparison tables where applicable" to get side-by-side summaries (e.g., ADH vs Aldosterone effects).

---

---

Your FMG Exam Prompt Template

"I am preparing for the FMG exam. From [Subject Name] (e.g., Physiology / Anatomy / Biochemistry / Pathology), give me the high-yield hot topics from the chapter/topic: [Chapter or Topic Name] as covered in [Book Name, e.g., Guyton & Hall / Gray's Anatomy / Robbins / Harper's Biochemistry].

Please give me:

1. Must-read subtopics - the core concepts I cannot skip
2. Key facts and one-liners - short points most likely to appear as MCQs
3. Important numbers, values, and diagrams - anything numerical or visual that FMG frequently tests
4. MCQ traps and confusing points - common mistakes or closely-related concepts that trick students
5. Repeat topics - subtopics that appear again and again in FMG-pattern exams"

---

Example - Ready to Copy and Send

"I am preparing for the FMG exam. From Physiology, give me the high-yield hot topics from the chapter Renal System as covered in Guyton & Hall.

Please give me:

1. Must-read subtopics - the core concepts I cannot skip
2. Key facts and one-liners - short points most likely to appear as MCQs
3. Important numbers, values, and diagrams - anything numerical or visual that FMG frequently tests
4. MCQ traps and confusing points - common mistakes or closely-related concepts that trick students
5. Repeat topics - subtopics that appear again and again in FMG-pattern exams"

---

How to Use It - Step by Step

---

---

🫘 Renal System - FMG High-Yield Breakdown

Source: Guyton & Hall Textbook of Medical Physiology

---

1. MUST-READ SUBTOPICS (Core Concepts You Cannot Skip)

A. Glomerular Filtration Rate (GFR)

• GFR = 125 mL/min (180 L/day filtered; only ~1.5 L excreted)
• Renal blood flow = 1100 mL/min = 22% of cardiac output (kidneys are only 0.4% of body weight!)
• Filtration fraction = GFR / Renal Plasma Flow = ~0.2 (20%)
• Net filtration pressure = Glomerular hydrostatic (60) - Bowman capsule pressure (18) - Colloid osmotic pressure (32) = +10 mmHg
• Kf (filtration coefficient) = GFR / Net filtration pressure = 12.5 mL/min per mmHg - Guyton, p. 338

B. Urine Formation - The Big Equation

Urinary Excretion = Filtration - Reabsorption + Secretion

• Glomerular filtrate is virtually protein-free (like plasma minus proteins)
• Tubular reabsorption is quantitatively large and highly selective - Guyton, p. 329
• Glucose and amino acids: ~100% reabsorbed
• Creatinine: filtered only, NOT reabsorbed - used to estimate GFR
• K+, H+: primarily handled by tubular secretion

C. Renal Clearance

• Clearance formula: C = (U × V) / P
• Inulin clearance = gold standard for GFR (freely filtered, not reabsorbed, not secreted)
• Creatinine clearance = clinical estimate of GFR (small amount is secreted, but errors cancel out)
• PAH (para-aminohippuric acid) clearance = measures renal plasma flow (almost completely secreted)

D. Tubular Reabsorption - Segment by Segment

E. Countercurrent Mechanism (Most Diagram-Heavy Topic)

• ~25% of nephrons are juxtamedullary - these create the medullary gradient
• Medullary osmolarity builds from 300 mOsm/L (cortex) up to 1200-1400 mOsm/L (papilla)
• The thick ascending limb pumps out a 200 mOsm/L gradient at a time
• Ascending limb: impermeable to water - this is the engine of concentration
• Vasa recta = countercurrent exchanger, preserves the medullary gradient
• Urea from inner medullary collecting duct contributes to the medullary hyperosmolarity
• Collecting duct passes through the hypertonic medulla - ADH makes it permeable to water, concentrating urine

F. Hormonal Regulation of the Kidney

• ADH (vasopressin): acts on collecting duct - inserts aquaporin-2 channels - water reabsorption
• Aldosterone: acts on principal cells of collecting duct - increases Na+ reabsorption, K+ secretion
• Renin-Angiotensin-Aldosterone System (RAAS): decreased RBF/Na+ delivery to macula densa - renin release - Ang I - ACE - Ang II - aldosterone
• ANP (Atrial Natriuretic Peptide): released when atria are stretched - increases GFR, inhibits aldosterone and ADH - natriuresis

G. Autoregulation of GFR and RBF

• Myogenic mechanism: afferent arteriole constricts when stretched - keeps GFR stable when BP rises
• Tubuloglomerular feedback (TGF): macula densa senses high NaCl - adenosine - afferent arteriole constriction - reduces GFR
• Autoregulation works over MAP 75-160 mmHg

---

2. KEY FACTS AND ONE-LINERS (MCQ-Ready)

• GFR = 125 mL/min; RBF = 1100 mL/min; RPF = ~625 mL/min; Filtration fraction = 20%
• Kidneys receive 22% of cardiac output but are only 0.4% of body weight
• Inulin = gold standard for GFR; PAH = gold standard for renal plasma flow
• The glomerular filtrate is essentially protein-free plasma
• Thick ascending limb: impermeable to water - this is what creates the medullary gradient
• Descending limb: permeable to water, impermeable to solutes
• Medullary interstitium osmolarity at papillary tip = 1200-1400 mOsm/L
• More than 99% of filtered water is reabsorbed
• Peritubular capillary reabsorption rate ≈ 124 mL/min (net reabsorptive force = 10 mmHg)
• Kf of glomerular capillaries = 400 times that of most other capillary beds
• Creatinine: filtered + slightly secreted - overestimates GFR slightly but errors cancel out clinically
• Urea: partly reabsorbed (~50%) - used to distinguish prerenal from intrinsic renal failure (BUN:Cr ratio)
• Bowman capsule hydrostatic pressure = 18 mmHg - raises it = decreases GFR (e.g., ureteral obstruction)

---

3. IMPORTANT NUMBERS, VALUES, AND DIAGRAMS

Critical Numbers Table

Must-Know Diagrams

1. Fig 26.6 (Guyton p. 328) - Filtration - Reabsorption + Secretion = Excretion
2. Countercurrent multiplier diagram - ascending vs descending loop osmolarity gradient
3. Starling forces at glomerulus (4 forces, net = +10 mmHg)
4. Autoregulation curve - GFR stable from 75-160 mmHg MAP
5. RAAS pathway - renin - Ang I - ACE - Ang II - aldosterone

---

4. MCQ TRAPS AND CONFUSING POINTS

• Both are impermeable to water, BUT the thick ascending limb has the active NKCC2 pump (furosemide target). The thin ascending limb is passively permeable to NaCl.

• Inulin = perfect GFR marker (no secretion, no reabsorption)
• Creatinine = slightly secreted, so creatinine clearance SLIGHTLY overestimates GFR - but clinically acceptable

• PAH clearance = renal PLASMA flow (~625 mL/min)
• To get renal BLOOD flow: RBF = RPF / (1 - hematocrit)

• Afferent arteriole constriction = decreases GFR (less blood in)
• Efferent arteriole constriction = increases GFR (traps blood in glomerulus, raises pressure)
• But SEVERE efferent constriction eventually reduces GFR (reduces plasma flow too much)

• Ureteral stone/obstruction → raises Bowman capsule pressure → decreases GFR (pressure opposes filtration)

• ADH: collecting duct (water permeability) - controlled by osmolarity
• Aldosterone: collecting duct principal cells (Na+ reabsorption, K+ secretion) - controlled by volume/K+

• Not because of their own metabolism - because of active Na+ reabsorption - O2 consumption parallels Na+ reabsorption rate

• GFR is ~10% lower in women than men (even after body size correction)

---

5. REPEAT TOPICS (Appear Again and Again in FMG-Pattern Exams)

---

---

🧬 Neoplasia - FMG High-Yield Breakdown

Source: Robbins & Kumar Basic Pathology (Robbins Pathology)

---

1. MUST-READ SUBTOPICS (Core Concepts You Cannot Skip)

A. Nomenclature - The Foundation

Key rule: All malignant epithelial tumors = Carcinoma. All malignant mesenchymal tumors = Sarcoma. Regardless of germ layer origin. - Robbins p. 215

B. Characteristics of Benign vs. Malignant Tumors

Anaplasia = lack of differentiation. Features: pleomorphism, hyperchromatism, high N:C ratio, atypical mitoses, loss of polarity - Robbins p. 216

C. Metastasis - Routes and Organ Preferences

• Carcinomas prefer lymphatic spread first
• Sarcomas prefer hematogenous spread (via thin-walled veins)
• Portal blood → Liver (colon, stomach, pancreas cancer)
• Caval blood → Lungs (most other carcinomas)
• Paravertebral plexus → Spine (thyroid, prostate cancer)
• Skip metastases: cancer cells bypass proximal nodes

D. Hallmarks of Cancer (Robbins - Must Know All 8)

1. Self-sufficiency in growth signals (oncogenes activated)
2. Insensitivity to growth inhibitory signals (tumor suppressors lost)
3. Evasion of apoptosis (BCL2 overexpression, p53 loss)
4. Limitless replicative potential (telomerase reactivation)
5. Sustained angiogenesis (VEGF production)
6. Invasion and metastasis (E-cadherin loss, MMP activation)
7. Altered cellular metabolism (Warburg effect - aerobic glycolysis)
8. Evasion of immune surveillance (PD-L1 upregulation)

E. Oncogenes and Tumor Suppressor Genes

F. Carcinogenesis - Chemical, Radiation, Viral

• Direct-acting carcinogens (don't need metabolic activation): alkylating agents (used in chemotherapy - can cause secondary cancers)
• Indirect-acting/Procarcinogens (need activation): Benzo[a]pyrene (cigarette smoke), aflatoxin (liver cancer), azo dyes, nitrosamines

• Ionizing radiation → DNA mutations (thyroid cancer, leukemia)
• UV rays → Pyrimidine dimers → error-prone repair → skin cancer

G. Clinical Aspects of Neoplasia

• Progressive loss of fat + lean mass, weakness, anorexia, anemia
• Caused by TNF + cytokines (NOT just reduced food intake)
• BMR is increased in cancer cachexia (opposite of starvation)
• TNF inhibits lipoprotein lipase → no free fatty acid release
• No treatment except tumor removal

• NOT due to local invasion or normal hormone secretion
• Most common: Hypercalcemia, Cushing syndrome, Nonbacterial thrombotic endocarditis
• Most common tumors involved: Lung and Breast cancers

---

2. KEY FACTS AND ONE-LINERS (MCQ-Ready)

• Metastasis = hallmark of malignancy (a tumor that doesn't metastasize = benign regardless of how bad it looks)
• RAS = most commonly mutated oncogene in human tumors (~20% of all cancers)
• TP53 = most commonly mutated tumor suppressor in all human cancers
• BCR-ABL t(9;22) = Philadelphia chromosome = CML (imatinib target)
• MYC t(8;14) = Burkitt lymphoma (jaw mass in African children)
• BCL2 t(14;18) = Follicular lymphoma = anti-apoptotic (overexpressed)
• HER2 amplified in ~20% of breast cancers - target of trastuzumab
• Warburg effect = cancer cells prefer aerobic glycolysis even when O2 is available
• Carcinomas = lymphatic spread first; Sarcomas = hematogenous spread first
• Teratoma = all 3 germ layers; originates from totipotent germ cells (ovary, testis, midline)
• Pleomorphic adenoma = most common salivary gland tumor (parotid); benign mixed tumor
• Sentinel lymph node = first node receiving lymph from tumor; biopsy = assess spread
• RB gene = G1-S checkpoint; phosphorylation by Cyclin D-CDK4/6 releases E2F → cell cycle entry
• p53 → DNA damage → p21 → sustained RB → G1-S block → repair → OR apoptosis/senescence
• Tumor promoters do NOT cause mutations themselves; they stimulate proliferation of mutated cells
• UV radiation → Pyrimidine dimers (specifically thymine-thymine)
• HPV E6 = inactivates p53; HPV E7 = inactivates RB
• Aflatoxin = hepatocellular carcinoma (mold on groundnuts/grains)
• Xeroderma pigmentosum = defective nucleotide excision repair → skin cancers
• Lynch syndrome (HNPCC) = mismatch repair defect → microsatellite instability → colon cancer
• Li-Fraumeni syndrome = germline TP53 mutation → diverse tumors

---

3. IMPORTANT NUMBERS, VALUES, AND DIAGRAMS

Key Numbers Table

Must-Know Diagrams

1. Benign vs Malignant comparison (Fig 6.10 Robbins) - leiomyoma vs leiomyosarcoma
2. Hallmarks of Cancer diagram - all 8 hallmarks
3. RB pathway - Cyclin D-CDK4/6 → phosphorylates RB → releases E2F → S phase
4. p53 pathway - DNA damage → p53 activation → p21 → G1 arrest OR apoptosis
5. RAS signaling - GDP (inactive) → GTP (active) → GAP normally turns it off → mutant RAS is stuck "on"
6. t(9;22) Philadelphia chromosome - BCR-ABL fusion
7. Routes of metastasis - lymphatic vs hematogenous, portal vs caval

---

4. MCQ TRAPS AND CONFUSING POINTS

• NO. A 1-cm pituitary adenoma (benign) can cause hypopituitarism. A 0.5-cm bile duct carcinoma can cause fatal obstruction. Location matters as much as size.

• All malignant epithelial tumors = Carcinoma (regardless of which germ layer the epithelium came from)
• "Renal tubular epithelium comes from mesoderm, so malignancy = sarcoma?" WRONG - it's called renal cell carcinoma.

• Oncogenes = dominant (one bad copy enough)
• Tumor suppressors = recessive (need to lose both - Knudson's "two-hit hypothesis" for RB)

• It is from cytokines (TNF) produced by macrophages/tumor cells
• BMR is INCREASED (not decreased as in starvation)

• Driver = causes cancer
• Passenger = neutral BUT can become a driver under selective pressure (e.g., after chemotherapy - drug resistance)

• Common mistake: students think BCL2 causes cell proliferation
• BCL2 prevents cell death (apoptosis evasion), NOT proliferation
• Follicular lymphoma accumulates slowly because cells WON'T die

• Cancer cells use glycolysis even in the PRESENCE of oxygen (aerobic glycolysis)
• NOT because of mitochondrial dysfunction - it's an active metabolic reprogramming for building blocks

• In children (ovary/testis): usually benign mature teratoma
• In postpubertal testis: mature teratoma = considered malignant (opposite of ovary!)
• Sacrococcygeal teratoma = most common teratoma in newborns

• Enlarged node ≠ metastasis automatically
• Can be reactive hyperplasia (lymphadenitis) from tumor antigens
• Biopsy is required to confirm

---

5. REPEAT TOPICS (Appear Again and Again in FMG-Pattern Exams)

---

1. Naming rules + common exceptions (melanoma, lymphoma, leukemia, seminoma, hepatoma - all malignant despite unusual names)
2. Translocations - one MCQ type that is extremely predictable
3. Paraneoplastic syndromes table - small cell lung cancer is the most common culprit
4. Two-hit hypothesis (Knudson) - RB gene model, germline vs somatic mutations

---

🧬 Neoplasia MCQ — Question 1 of 10

---

• A) Renal sarcoma
• B) Renal cell carcinoma
• C) Renal mesenchymoma
• D) Renal cell sarcoma

---

✅ Answer: B) Renal cell carcinoma

"Malignant neoplasms of epithelial cells are called carcinomas regardless of the tissue of origin." - Robbins p. 215

---

---

🧬 Neoplasia — 10 FMG MCQs with Answers & Explanations

---

Q1. Naming / Nomenclature

• A) Esophageal sarcoma
• B) Esophageal squamous cell carcinoma
• C) Esophageal squamous sarcoma
• D) Esophageal adenocarcinoma

✅ Answer: B

---

Q2. Hallmark of Malignancy

• A) Large size
• B) Rapid growth
• C) Ability to metastasize
• D) Presence of necrosis

✅ Answer: C

---

Q3. Oncogenes

• A) Stimulating tumor suppressor genes
• B) Remaining permanently bound to GTP, unable to hydrolyze it
• C) Losing the ability to bind GTP
• D) Activating GAP (GTPase-activating protein)

✅ Answer: B

"Activated RAS stimulates downstream regulators of proliferation... mutant RAS is constitutively active." - Robbins

---

Q4. Tumor Suppressor - RB Gene

• A) RB promotes cell cycle progression from G1 to S phase
• B) RB, when unphosphorylated, binds E2F and prevents G1-to-S transition
• C) RB is activated by phosphorylation via Cyclin D-CDK4/6
• D) RB activates growth-promoting transcription factors

✅ Answer: B

---

Q5. TP53 - Guardian of the Genome

• A) The cell is immediately destroyed by NK cells
• B) The cell undergoes normal apoptosis via the extrinsic pathway
• C) The damaged DNA is not repaired and the cell continues to replicate with mutations
• D) The cell arrests in S phase permanently

✅ Answer: C

---

Q6. Chromosomal Translocation

• A) t(8;14) - MYC/IgH fusion
• B) t(14;18) - BCL2/IgH fusion
• C) t(9;22) - BCR-ABL fusion
• D) t(11;14) - Cyclin D/IgH fusion

✅ Answer: C

• t(8;14) = Burkitt lymphoma (MYC overexpression)
• t(14;18) = Follicular lymphoma (BCL2 overexpression - anti-apoptosis)
• t(11;14) = Mantle cell lymphoma (Cyclin D1)

---

Q7. Metastasis Pattern

• A) Portal venous system
• B) Caval venous system
• C) Paravertebral (Batson's) venous plexus
• D) Lymphatic spread to paraaortic nodes

✅ Answer: C

---

Q8. Viral Carcinogenesis

• A) HPV directly mutates the RAS gene
• B) HPV E6 protein inactivates RB; HPV E7 protein inactivates p53
• C) HPV E6 protein inactivates p53; HPV E7 protein inactivates RB
• D) HPV causes chromosomal translocation t(9;22)

✅ Answer: C

---

Q9. Paraneoplastic Syndrome

• A) Renal metastasis causing salt wasting
• B) Ectopic PTHrP secretion by the tumor
• C) Ectopic ADH secretion by small cell lung carcinoma
• D) Adrenal insufficiency from metastatic disease

✅ Answer: C

• Ectopic ADH → SIADH
• Ectopic ACTH → Cushing syndrome
• Lambert-Eaton syndrome (anti-VGCC antibodies)

---

Q10. Cancer Cachexia

• A) Reduced caloric intake leading to starvation response
• B) Tumor physically compressing the intestine, reducing absorption
• C) TNF and pro-inflammatory cytokines released by macrophages and tumor cells
• D) Elevated cortisol from adrenal metastasis

✅ Answer: C

• Suppress appetite
• Inhibit lipoprotein lipase (no fat storage)
• Increase basal metabolic rate (ELEVATED in cachexia, unlike starvation where it drops)

---

📊 Your Score Card

---